Abstract
Introduction
Transvenous ventricular pacing leads across the tricuspid valve may cause or exacerbate tricuspid regurgitation (TR). The literature in adults is inconclusive and no studies have investigated the association between pacing leads and TR in children or congenital heart disease patients.
Methods and results
A retrospective chart review was conducted at a large children’s hospital, yielding 123 patients with initial placement of a transvenous lead across their tricuspid valve that had adequate echocardiographic data for review. The median age was 16 years (range 2–52) at time of lead placement. The pre-procedure echo was compared both to the first echo after lead placement and the most recent echo. Median time was 242 days from implant to first echo, and 827 days to most recent echo. There was no difference in TR between the pre-procedure echo and first follow-up echo (p = NS). However, TR was more likely to progress mildly between the pre-procedure echo and the most recent echo (p < 0.02) with a mean increase from 1.54 to 1.69 on a 0 to 4 ordinal scale. There were 76 pts (62%) with CHD. Mean pre-procedure TR was 1.82 in right-sided valvular CHD (e.g., tetralogy of Fallot, repaired AV canal) vs. 1.43 without right-sided CHD (p < 0.01).
Conclusions
In patients with transvenous ventricular leads across the tricuspid valve, echocardiography demonstrates a small, but statistically significant change in TR. The detected change is minimal, suggesting that there is little impact of transvenous leads on TR, even in growing children or patients with right-sided structural heart disease.
Similar content being viewed by others
References
Furman, S., & Schwedel, J. (1959). An intracardiac pacemaker for Stokes–Adams seizures. New England Journal of Medicine, 261, 943–948.
Gregoratos, G., Abrams, J., Epstein, A. E., Freedman, R. A., Hayes, D. L., Hlatky, M. A., et al. (2002). American College of Cardiology/American Heart Association Task Force on Practice Guidelines American College of Cardiology/American Heart Association/North American Society for Pacing and Electrophysiology Committee. ACC/AHA/NASPE 2002 guideline update for implantation of cardiac pacemakers and antiarrhythmia devices: Summary article: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Journal of Cardiovascular Electrophysiology, 13, 1183–1199.
Gibson, T. V., Davidson, R. C., & DeSilvey, D. L. (1980). Presumptive tricuspid valve malfunction induced by a pacemaker lead: a case report and review of the literature. PACE, 3, 88–93.
Iskandar, S. B., Jackson, S. A., Fahrig, S., Mechleb, B. K., & Garcia, I. D. (2006). Tricuspid lead malfunction and ventricular pacemaker lead: case report and review of the literature. Echocardiography, 23, 692–696.
Paniagua, D., Aldrich, H. R., Lieberman, E. H., Lamas, G. A., & Agatston, A. S. (1998). Increased prevalence of significant tricuspid regurgitation in patients with transvenous pacemakers leads. American Journal of Cardiology, 82, 1130–1132 (A9).
Leibowitz, D. W., Rosenheck, S., Pollak, A., Geist, M., & Gilon, D. (2000). Transvenous pacemaker leads do not worsen tricuspid regurgitation: a prospective echocardiographic study. Cardiology, 93, 74–77.
Stevenson, G. J. (1984). Experience with qualitative and quantitative applications of Doppler echocardiography in congenital heart disease. Ultrasound in Medicine & Biology, 10, 771–796.
Kuczmarski, R. J., Ogden, C. L., Grummer-Strawn, L. M., Flegal, K. M., Guo, S. S., Wei, R., et al. (2000). CDC growth charts: United States. Advance Data, 314, 1–27.
Mosteller, R. D. (1987). Simplified calculation of body-surface area. New England Journal of Medicine, 317, 1098.
Fortescue, E. B., Berul, C. I., Cecchin, F., Triedman, J. K., Walsh, E. P., & Alexander, M. E. (2004). Patient, procedural, and hardware factors associated with pacemaker lead failures in pediatrics and congenital heart disease. Heart Rhythm, 1, 150–159.
Bar-Cohen, Y., Berul, C. I., Alexander, M. E., Fortescue, E. B., Walsh, E. P., Triedman, J. K., et al. (2006). Age, size, and lead factors alone do not predict venous obstruction in children and young adults with transvenous lead systems. Journal of Cardiovascular Electrophysiology, 17, 754–759.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Webster, G., Margossian, R., Alexander, M.E. et al. Impact of transvenous ventricular pacing leads on tricuspid regurgitation in pediatric and congenital heart disease patients. J Interv Card Electrophysiol 21, 65–68 (2008). https://doi.org/10.1007/s10840-007-9183-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10840-007-9183-0